The Cancer Letter

Inside information on cancer research and drug development

Vol.
30
No.
5
May 25, 2007May 25, 2007
Free
DOWNLOAD THE PDF

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

Phase II Study Finds Dasatinib May Overcome ALL Resistance

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

Risk of Lymphoma Increases with Hepatitis C Virus Infection

Long-Term Results Find Cisplatin Improves Survival

Study Links Ovarian Cancer To Hormone Replacement

Smokers Who Quit Live Longer Than Those Who Spit-Study

FDA Approves New Drug for Advanced Kidney Cancer

FDA Approves New Indication For Anticoagulant Frangmin

NCI-Approved Group, Center Clinical Trials Listed

Login

Looking for IP Login?